Diabetes Tools Sweden AB

Diabetes Tools readies US market entry

Press release   •   Aug 26, 2013 08:00 UTC

Swedish medtech company Diabetes Tools is signaling its intentions towards the American healthcare market by hiring a Senior Director of Business Development for the United States. Industry veteran Björn Nordwall is tasked with engaging the US market about Triabetes™, Diabetes Tools’ patient-centered, online lifestyle decision support service for the control of all forms of diabetes.

“As a company, we are taking our first strategic step towards the US healthcare market by appointing Björn,” said Diabetes Tools’ Chief Executive Officer Anders Weilandt. “His deep understanding of the diabetes treatment and mHealth industries plays into our preparations to extend our market presence to the USA.”

Björn Nordwall comes to Diabetes Tools from business strategy consultants Motion Venture. Before that, Björn was CEO of a wireless chronic disease management startup called Confidant and also held US-based senior marketing positions for Motorola and Ericsson. He starts his role at Diabetes Tools immediately and is located in North Carolina, USA.

Triabetes status

Triabetes was made publically available as an Android™ smartphone app and personal online account in Sweden during April 2013. The iPhone™ version followed in August as did a monthly subscription package offering more features called Triabetes+. For diabetes healthcare providers, Triabetes Clinic takes a larger scale approach and is available for integration on request.

From a regulatory perspective, Triabetes is a CE-marked medical software product registered for sale in the European Union. Currently, it is not cleared nor offered for sale in the USA.

Triabetes is a trademark of Diabetes Tools Sweden AB. Android is a trademark of Google Inc. iPhone is a trademark of Apple Inc., registered in the U.S. and other countries.

About Triabetes and Diabetes Tools

Triabetes is a smartphone app and online decision support service for people living with and caring for all forms of diabetes. Triabetes is from Diabetes Tools, a Swedish medical technology company that develops scientifically based Software-as-a-Service solutions. Triabetes is scalable. It can be used by individuals, doctors and treatment clinics, and can be integrated with large-scale Electronic Medical Record (EMR) systems.

Founded in 2005, Diabetes Tools is a privately held company located in Stockholm, Sweden. Diabetes Tools holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services. Triabetes is a CE-marked medical software product registered for sale in the European Union. More information at http://www.diabetestools.se.